<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lear TB</submitter><funding>NIAMS</funding><funding>NHLBI</funding><funding>NIDDK NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>NHBLI</funding><funding>NIAMS NIH HHS</funding><funding>NIDDK</funding><pagination>129110</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6795399</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>4(19)</volume><pubmed_abstract>Dysregulated proinflammatory cytokine release has been implicated in the pathogenesis of several life-threatening acute lung illnesses such as pneumonia, sepsis, and acute respiratory distress syndrome. Suppressors of cytokine signaling proteins, particularly SOCS2, have recently been described as antiinflammatory mediators. However, the regulation of SOCS2 protein has not been described. Here we describe a mechanism of SOCS2 regulation by the action of the ubiquitin E3 ligase KIAA0317. KIAA0317-mediated degradation of SOCS2 exacerbated inflammation in vitro, and depletion of KIAA0317 in vivo ameliorated pulmonary inflammation. KIAA0317-knockout mice exhibited resistance to LPS-induced pulmonary inflammation, while KIAA03017 reexpression mitigated this effect. We uncovered a small molecule</pubmed_abstract><journal>JCI insight</journal><pubmed_title>KIAA0317 regulates pulmonary inflammation through SOCS2 degradation.</pubmed_title><pmcid>PMC6795399</pmcid><funding_grant_id>R01 DK119627</funding_grant_id><funding_grant_id>DK119627</funding_grant_id><funding_grant_id>R35 HL139860</funding_grant_id><funding_grant_id>P01 HL114453</funding_grant_id><funding_grant_id>HL144820</funding_grant_id><funding_grant_id>HL139860</funding_grant_id><funding_grant_id>HL143843</funding_grant_id><funding_grant_id>HL142777</funding_grant_id><funding_grant_id>HL133184</funding_grant_id><funding_grant_id>AR060780</funding_grant_id><funding_grant_id>P50 AR060780</funding_grant_id><funding_grant_id>F31 HL143843</funding_grant_id><funding_grant_id>T32 HL007563</funding_grant_id><funding_grant_id>R01 HL133184</funding_grant_id><funding_grant_id>K08 HL144820</funding_grant_id><funding_grant_id>R01 HL142777</funding_grant_id><pubmed_authors>Burton CL</pubmed_authors><pubmed_authors>Rajbhandari S</pubmed_authors><pubmed_authors>Dunn SR</pubmed_authors><pubmed_authors>McKelvey AC</pubmed_authors><pubmed_authors>Shlomchik MJ</pubmed_authors><pubmed_authors>Evankovich JW</pubmed_authors><pubmed_authors>Gingras S</pubmed_authors><pubmed_authors>Lafyatis R</pubmed_authors><pubmed_authors>Chen BB</pubmed_authors><pubmed_authors>Lockwood KC</pubmed_authors><pubmed_authors>Valenzi E</pubmed_authors><pubmed_authors>Gordon R</pubmed_authors><pubmed_authors>Londino JD</pubmed_authors><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Jurczak MJ</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Coon TA</pubmed_authors><pubmed_authors>Lear TB</pubmed_authors><pubmed_authors>McVerry BJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>KIAA0317 regulates pulmonary inflammation through SOCS2 degradation.</name><description>Dysregulated proinflammatory cytokine release has been implicated in the pathogenesis of several life-threatening acute lung illnesses such as pneumonia, sepsis, and acute respiratory distress syndrome. Suppressors of cytokine signaling proteins, particularly SOCS2, have recently been described as antiinflammatory mediators. However, the regulation of SOCS2 protein has not been described. Here we describe a mechanism of SOCS2 regulation by the action of the ubiquitin E3 ligase KIAA0317. KIAA0317-mediated degradation of SOCS2 exacerbated inflammation in vitro, and depletion of KIAA0317 in vivo ameliorated pulmonary inflammation. KIAA0317-knockout mice exhibited resistance to LPS-induced pulmonary inflammation, while KIAA03017 reexpression mitigated this effect. We uncovered a small molecule</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Oct</publication><modification>2026-04-15T23:16:57.632Z</modification><creation>2019-11-07T08:04:43Z</creation></dates><accession>S-EPMC6795399</accession><cross_references><pubmed>31578312</pubmed><doi>10.1172/jci.insight.129110</doi></cross_references></HashMap>